Fri, Aug 29, 2014, 9:11 AM EDT - U.S. Markets open in 19 mins.

Recent

% | $
Quotes you view appear here for quick access.

Illumina Inc. Message Board

  • texexec60 texexec60 Nov 16, 2012 2:29 PM Flag

    GlaxoSmithKline rumored to be eyeing Illumina, Independent reports

     

    November 16, 2012

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Illumina Inc. (ILMN), the U.S. leader in genetic sequencing, said it had offered $3.30 a share to acquire rival Complete Genomics Inc. (GNOM), or 5 percent more than the bid from BGI-Shenzhen that was accepted by the company.

      Complete Genomics considered Illumina’s offer “inadequate” because of the likelihood the deal wouldn’t receive clearance from antitrust regulators, the Mountain View, California-based company said today in a filing. The company named the bidder only as “Party H.”

      BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics in September for $3.15 a share, or about $117.6 million, to expand in the U.S. market for medical and research DNA testing. The board of Complete Genomics has unanimously recommended that stockholders accept BGI’s offer.

      Illumina, based in San Diego, said in a filing today that its offer was in cash and came without “any condition for further due diligence.”

 
ILMN
179.08Aug 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Williams-Sonoma Inc.
NYSEThu, Aug 28, 2014 4:02 PM EDT
Veeva Systems Inc.
NYSEThu, Aug 28, 2014 4:01 PM EDT